Search Results 371-380 of 24303 for B cell lymphomas

  1. Ellen D. McPhail, M.D. - Mayo Clinic Faculty Profiles

    ... B-cell lymphoma with MYC gene, and BCL2 gene rearrangements known as double-hit lymphomas and large B-cell lymphomas with IRF4 gene rearrangements.

  2. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

    ... B‐Cell Lymphoma patients. Participation eligibility. Participant eligibility ... Note: Subjects with Diffuse Large B-Cell Lymphoma (DLBCL) and Small ...

  3. Clinical trials - Oncology (Medical)

    ... B-cell lymphoma 2 (BCL2) inhibitor. MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori ...

  4. Oncology (Medical) - Clinical trials

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

  5. Peripheral T-cell lymphoma - Care at Mayo Clinic

    Learn about this type of non-Hodgkin lymphoma that affects the lymph nodes and can spread to the organs. Find out about symptoms, diagnosis and treatments.

  6. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies (MorningSun) - Mayo Clinic

    ... B-cell malignancies (types of non-Hodgkin's lymphoma [NHL]). Participation ... - High-grade B-cell lymphomas, not otherwise specified (HGBL NOS) and HGBL with MYC ...

  7. Clinical trials - Oncology (Medical)

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

  8. Advancing CAR-T cell therapy through clinical trials at Mayo Clinic in Arizona

    Trials like these have led to FDA approval of CAR-T cell therapies in second-line treatment of relapsed/refractory diffuse large B-cell lymphoma. Clinical ...

  9. Lymphoma - Doctors and departments - Mayo Clinic

    Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...

  10. Quality of Life at Diagnosis May Predict Survival for Patients With Aggressive Lymphoma - Mayo Clinic News Network

    Sixty percent of patients had a diagnosis of diffuse large B-cell lymphoma, 14 percent mantle cell lymphoma, 11 percent grade III follicular lymphoma, 13 ...